Strategies for loading dendritic cells with hepatitis C NS5a antigen and inducing protective immunity (Q43047446)

12 November 2017

title

Strategies for loading dendritic cells with hepatitis C NS5a antigen and inducing protective immunity (English)

1 reference

12 November 2017

1 reference

H Yu

1 reference

12 November 2017

L A Babiuk

series ordinal

1 reference

12 November 2017

S van Drunen Littel-van den Hurk

series ordinal

1 reference

12 November 2017

language of work or name

1 reference

24 January 2008

1 reference

Journal of Viral Hepatitis

12 November 2017

published in

1 reference

12 November 2017

1 reference

12 November 2017

1 reference

12 November 2017

page(s)

459-470

1 reference

Hepatitis B and hepatitis C viruses in liver transplantation

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00959.X

Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00959.X

Treatment of chronic hepatitis C infection with peginterferons plus ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00959.X

DNA prime-canarypox boost with polycistronic hepatitis C virus (HCV) genes generates potent immune responses to HCV structural and nonstructural proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00959.X

Memory T cells and vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00959.X

T cell response in hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00959.X

Hepatitis C virus genetic variability: pathogenic and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00959.X

Viral heterogeneity of the hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00959.X

Development of a hepatitis C virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00959.X

Primary and memory T cell responses induced by hepatitis C virus multiepitope long peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00959.X

Broad repertoire of the CD4+ Th cell response in spontaneously controlled hepatitis C virus infection includes dominant and highly promiscuous epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00959.X

Dendritic cells as vectors for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00959.X

Dendritic cells: a journey from laboratory to clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00959.X

Dendritic cells induce immunity and long-lasting protection against blood-stage malaria despite an in vitro parasite-induced maturation defect

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00959.X

Adenovirus-transduced dendritic cells injected into skin or lymph node prime potent simian immunodeficiency virus-specific T cell immunity in monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00959.X

Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans. Implications for initiation of T helper cell immunity in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00959.X

Dendritic cells (DC) activated by CpG DNA ex vivo are potent inducers of host resistance to an intracellular pathogen that is independent of IL-12 derived from the immunizing DC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00959.X

Immunity and protection by adoptive transfer of dendritic cells transfected with hepatitis C NS3/4A mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00959.X

Dendritic cells transfected with cytopathic self-replicating RNA induce crosspriming of CD8+ T cells and antiviral immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00959.X

Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by immunization with dendritic cells transduced with replication-defective recombinant adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00959.X

Prophylactic and therapeutic vaccination with dendritic cells against hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00959.X

Viral subversion of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00959.X

Poxvirus as a vector to transduce human dendritic cells for immunotherapy: abortive infection but reduced APC function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00959.X

Vaccinia virus-related events and phenotypic changes after infection of dendritic cells derived from human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00959.X

Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00959.X

Rapid induction of cytotoxic T-cell response against cervical cancer cells by human papillomavirus type 16 E6 antigen gene delivery into human dendritic cells by an adeno-associated virus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00959.X

Dendritic cells pulsed with hepatitis C virus NS3 protein induce immune responses and protection from infection with recombinant vaccinia virus expressing NS3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00959.X

The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus Emulsigen are increased by formulation with CpG oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00959.X

Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00959.X

DNA immunization with hepatitis C virus (HCV) polycistronic genes or immunization by HCV DNA priming-recombinant canarypox virus boosting induces immune responses and protection from recombinant HCV-vaccinia virus infection in HLA-A2.1-transgenic mi

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00959.X

Delivery of tumor-derived RNA for the induction of cytotoxic T-lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00959.X

Cancer immunotherapy with mRNA-transfected dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00959.X

Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by immunization with dendritic cells treated with an anthrax toxin fusion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00959.X

Vaccination with protein-transduced dendritic cells elicits a sustained response to hepatitis C viral antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00959.X

Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00959.X

Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00959.X

Dendritic cell-based tumor vaccine for cervical cancer I: in vitro stimulation with recombinant protein-pulsed dendritic cells induces specific T cells to HPV16 E7 or HPV18 E7

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00959.X

10.1111/J.1365-2893.2008.00959.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference